NCT04051827 2025-07-28
Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
Takeda
Phase 1 Completed
Takeda
Washington University School of Medicine
Astellas Pharma Inc
Pfizer
Trinity Health Michigan
Takeda
Eli Lilly and Company
Daiichi Sankyo
Eli Lilly and Company
Eisai Inc.
Mount Carmel Health System
Beijing Tiantan Hospital
Genentech, Inc.
M.D. Anderson Cancer Center
Mayo Clinic